Mail & Guardian
Mail & Guardian
hiv vaccinelatest news & developments
Lenacapavir could end Aids in South Africa by 2032. How much should we pay for it? (Canva)
AIDS TREATMENT

The six-monthly anti-HIV jab could end Aids in SA by 2032

A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s while

  • Mia Malan
12 min read
The Global Fund for HIV, TB and Malaria says it will fund the roll-out of the twice-yearly anti-HIV jab, lenacapavir, for poorer countries, including South Africa, with or without the help of the US government’s Aids fund, Pepfar
AIDS

The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar

In December, the Global Fund and the US President’s Emergency Plan for Aids Relief committed to funding the roll-out of lenacapavir in countries they support

  • Ida Jooste
9 min read
South African Medical Research Council president and chief executive Glenda Gray is stepping down to take up a full-time scientific role.
COVID 19

Glenda Gray steps down from South African Medical Research Council

Gray is the first female president and chief executive of the council and served as the chairperson of the research committee on Covid-19

  • Lyse Comins
2 min read
The Covid-19 pandemic has shown that vaccine development and testing timelines can be shrunk from decades to months, but not without shortcomings. (Angel Garcia/Bloomberg via Getty Images)
AIDS

Finding an HIV vaccine: Five lessons from the search for a Covid-19 jab

The Covid-19 pandemic has shown that vaccine development and testing timelines can be shrunk from decades to months, but not without shortcomings

  • Fatima Hassan
6 min read
One of the first participants of the new vaccine trial recently received her first jab at one of several research cites in Durban.
HIV

Should everyone be getting the HIV prevention pill as part of this new study?

Only some study participants have access to the tablet that can cut the risk of HIV infection by more than 90%.

  • Nelisiwe Msomi
4 min read
One of the first participants of the new vaccine trial recently received her first jab at one of several research cites in Durban.
HIV VACCINE

What’s next for South Africa’s experimental HIV vaccine

If it works, the world’s latest HIV vaccine candidate may make it to market quicker than we think – and become a routine childhood vaccination

  • Laura Lopez Gonzalez
4 min read
I didn’t want her problems. Jane Mahlangu* says watching her HIV-positive friend struggle with raising an HIV-positive child inspired her to take part in a clinical trial that may be the world’s best hope for an HIV vaccine.
HIV

Why I signed up for an HIV vaccine trial

Jane Mahlangu is set to become one of the first 100 people in South Africa to receive an experimental jab that could prevent HIV – and make history

  • Laura Lopez Gonzalez
3 min read
What started as a bizarre press release touting a “potential HIV cure” has gone viral leading media houses all over the world to lash out over firm Zion Medical’s latest claims.
HIV PREVENTION STRATEGY

South Africa on the cusp of HIV vaccine breakthrough

Recently the first participants in the HVTN 702 study received jabs of a vaccine that could stop HIV in its tracks

  • Glenda Gray
5 min read
Will superantibodies produced in laboratories become our best bet for staving off HIV infection?
HIV PREVENTION STRATEGY

Could we mass-produce HIV immunity?

One tiny protein may hold the secret to ending the HIV pandemic.

  • Nono Mkhize
4 min read
HIV

Unique South African children may chart new path for HIV vaccines

A study conducted among almost 200 South African children is the largest of its kind.

  • Staff Reporter
3 min read
Knowing your HIV status could curb the spread of the virus
ANTIRETROVIRAL DRUGS

#AIDS2016: From medical circumcision to vaccines, these seven things will change HIV

We know more than ever about how to prevent HIV infection, including what may someday lead to the world’s first HIV vaccine.

  • Salim S Abdool Karim
6 min read
An Australian scientist has said he discovered how to turn HIV against itself to stop it progressing to Aids.
HIV

#AIDS2016 signals the beginning of research into a new generation of HIV vaccines

The time for an HIV vaccine is now

  • Glenda Gray
5 min read
Zero discrimination is essential to if we are to change the fact that 7.8 million South Africans live with HIV, but 5.8 million people are on ARVs, highlighting a treatment gap
AIDS VACCINES

HIV vaccine – closer than ever

We are not there yet, but experts are optimistic about a jab to prevent HIV coming to market in the near future.

  • Tian Johnson
  • Tian Johnson Guest Author
6 min read
AIDS VACCINES

Comment: HIV researchers, citizens must be part of decisions

If the progress we see today is anything to go by, it means we are closer than ever to having an HIV vaccine.

  • Ntando Yola
4 min read
Vodafone’s European operations have been earmarked as an attractive investment by AT&T.
HIV VACCINE

In search of an HIV vaccine

​Three SARChI Research Chairs are focusing on the holy grail of HIV vaccine development to develop a therapeutic vaccine against the virus.

  • Advertising Feature
  • Advertising Supplement
4 min read
Studies have shown that antiretroviral drug Truvada helps shield HIV-negative people from contracting HIV
HIV

Women confound HIV researchers

Why would young, single African women not take free drugs that could potentially save them from contracting a life-threatening infection?

  • Mia Malan
5 min read
HIV vaccine the only real answer
HIV VACCINE

HIV vaccine the only real answer

Access to antiretrovirals has increased tenfold, but efforts aimed at prevention must be renewed.

  • Staff Reporter
5 min read
HIV VACCINE

Trial of HIV vaccine ‘a milestone for SA’

Clinical testing of the first HIV vaccine developed in Africa will start in the US next week, the SA Aids Vaccine Initiative said on Friday.

  • Staff Reporter
3 min read
CAPE TOWN

Hunt for Aids vaccine pushes on

A year after a setback in the hunt for an HIV/Aids vaccine, researchers say their defeats have forced them to look for new ways of creating a defence.

  • Fran Blandy
3 min read